Atrial Fibrillation in Heart Failure with Preserved Left Ventricular Systolic Function: Distinct Elevated Risk for Cardiovascular Outcomes in Women Compared to Men.
Alaa Mabrouk Salem OmarMohamed Ahmed Abdel RahmanOsama RifaieJonathan N BellaPublished in: Journal of cardiovascular development and disease (2022)
Background: Heart failure with preserved ejection fraction (HFpEF) is prevalent in women and is associated with atrial fibrillation (AF). However, sex associations in AF-related HFpEF are not well explored. Aim: We studied differences between men and women with and without AF-related HFpEF symptoms on left ventricular (LV) geometry and diastolic dysfunction (DD) and their effect on cardiovascular events. Methods: Retrospectively, HFpEF patients with and without a history of AF referred for echocardiography were studied. Echocardiographic assessments were focused on LV geometry and diastolic functions. Patients were followed for the occurrence of cardiac events defined as death and cardiac hospitalization. Results: We studied 556 patients [age: 66.7 ± 17 years, 320 (58%) women, 91 (16%) AF]. Compared to HFpEF without AF (HFpEF-AF), HFpEF with AF patients (HFpEF+AF) were older (76 ± 13.8 vs. 64.9 ± 17.3 years, p < 0.001), had more risk factors, comorbidities, left ventricular hypertrophy (32 vs. 13%, p < 0.001), higher relative wall thickness (0.50 ± 0.14 vs. 0.44 ± 0.15, p < 0.001), and DD (56 vs. 30%, all p < 0.001). HFpEF+AF women had the worst clinical, LV geometric, and diastolic functional profiles and highest rates of cardiovascular outcomes compared to HFpEF+AF men and were the only group to predict outcomes (HR: 2.7, 95%CI: 1.4-5.1), while HFpEF-AF women were a low-risk group; HFpEF+AF and HFpEF-AF men had intermediate cardiovascular outcomes which were confirmed after propensity score matching. Conclusions: Among patients with HFpEF, women with AF had more abnormal LV geometry and diastolic function and had an increased risk of adverse cardiovascular outcomes independent of traditional risk factors, comorbidities, and baseline diastolic function.
Keyphrases
- atrial fibrillation
- left ventricular
- heart failure
- left atrial
- ejection fraction
- oral anticoagulants
- catheter ablation
- left atrial appendage
- aortic stenosis
- hypertrophic cardiomyopathy
- risk factors
- cardiac resynchronization therapy
- direct oral anticoagulants
- end stage renal disease
- blood pressure
- newly diagnosed
- acute myocardial infarction
- polycystic ovary syndrome
- mitral valve
- prognostic factors
- percutaneous coronary intervention
- coronary artery disease
- cardiovascular events
- patient reported outcomes
- emergency department
- pregnancy outcomes
- physical activity
- adipose tissue
- skeletal muscle
- computed tomography
- peritoneal dialysis
- transcatheter aortic valve replacement
- metabolic syndrome
- venous thromboembolism
- oxidative stress
- aortic valve
- depressive symptoms
- cervical cancer screening